Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | RA. Freedman, RS Gelman, ME. Melisko, CK. Anders, B Moy, KL. Blackwell, RM. Connolly, PA Niravath, CH. Van Poznak, S Puhalla, S Farooq, A Cropp, CM Cotter, MC. Liu, IE. Krop, JR. Nangia, NM. Tung, AC. Wolff, EP. Winer, NU. Lin | ||||||||||||
Title | TBCRC 022: Phase II trial of neratinib + capecitabine for patients (Pts) with human epidermal growth factor receptor 2 (HER2+) breast cancer brain metastases (BCBM). | ||||||||||||
|
|||||||||||||
URL | http://abstracts.asco.org/199/AbstView_199_186113.html | ||||||||||||
Abstract Text | J Clin Oncol 35, 2017 (suppl; abstr 1005) |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|